Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferio
about
Brain metastases from hepatocellular carcinoma: recent advances and future avenuesValidation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA).Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.Clinical Features of Brain Metastases in Small Cell Lung Cancer: an Implication for Hippocampal Sparing Whole Brain Radiation Therapy.Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer.Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases.A Neuro-oncologist's Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer.Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysisQuality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trial.Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.The Microenvironmental Landscape of Brain Tumors.Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy.Evaluation of Prognostic Factors for Early Mortality After Stereotactic Radiosurgery for Brain Metastases: a Single Institutional Retrospective Review.Whole brain radiotherapy for brain metastases from non-small cell lung cancer: the end of an era?Empirical Consequences of Current Recommendations for the Design and Interpretation of Noninferiority Trials.Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.Estimating prognosis at the time of repeat whole brain radiation therapy for multiple brain metastases: The reirradiation score.The radiosurgery fractionation quandary: single fraction or hypofractionation?Cerebrovascular Remodeling and Neuroinflammation is a Late Effect of Radiation-Induced Brain Injury in Non-Human Primates.Multi-Institutional Competing Risks Analysis of Distant Brain Failure and Salvage Patterns after Upfront Radiosurgery without Whole Brain Radiotherapy for Brain Metastasis.The rapidly evolving treatment landscape for patients with brain metastases from epidermal growth factor receptor mutated non-small cell lung cancer.Long-term Outcomes after Salvage Stereotactic Radiosurgery (SRS) following In-Field Failure of Initial SRS for Brain Metastases.Single fraction stereotactic radiosurgery for multiple brain metastases.A Four-Tiered Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer.Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation.Contraction of T cell richness in lung cancer brain metastases.Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?Hospice care, cancer-directed therapy, and Medicare expenditures among older patients dying with malignant brain tumors.Predicting prognosis of short survival time after palliative whole-brain radiotherapy.Emerging treatment paradigms for brain metastasis in non-small-cell lung cancer: an overview of the current landscape and challenges ahead.Prognostic value of pre- and post-treatment health-related quality of life in predicting survival of patients with brain metastases.Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease.Surgical approach in the oligometastatic patient.Role of Recursive Partitioning Analysis and Graded Prognostic Assessment on Identifying Non-Small Cell Lung Cancer Patients with Brain Metastases Who May Benefit from Postradiation Systemic Therapy.Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions.Mechanisms and Therapy for Cancer Metastasis to the Brain.Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion.
P2860
Q33649050-B2D23A98-E98A-4B8C-84E6-DA2FB2B33484Q33832902-2BFE6BDB-EE67-44DB-B824-CD42C72C3731Q36385818-61740BE3-C8B7-4D7C-9AAB-D74733E842DBQ37500421-92A01F9A-815E-436C-9C3F-A86A6203ADC4Q37702787-13C2BF54-1221-4AEA-A818-FAA581ACCDDDQ37717319-E43218C2-F430-49A5-A6B2-3C25877D6A4AQ37742623-4DE7B0B2-DD36-403B-BF5E-DC1388882A12Q38369616-A5DF97D4-926E-45BD-94F9-3DA8CDE40397Q38667233-25EBB508-CD68-4C8C-861E-99BE85A46F27Q38670864-A6AF2902-F971-42C4-9D9C-690206610F7AQ38937766-CBA27251-4D9E-4AE7-9DC1-3A7E8C596399Q39178065-B96ABDB8-30D0-4F4B-91F1-A08057ADC5A4Q39337110-7A3CFE7F-6CBD-416E-AEFD-9D26E6963AF3Q39411734-FB5133D6-F5E7-4233-97DA-0B9156E8BD21Q39717396-A858C33D-1FC9-41F2-82A2-6B124D820BD1Q40056576-5D3E9D1F-35CC-4CB6-A87C-4FA74587BEC6Q41117159-0E48D751-DC01-4C5C-A550-2B0E1553B229Q43379660-97127A7C-7AE8-45D2-B567-D5588784FA2AQ44455124-F69C9E35-A385-40C9-BB37-2AA1D15B5D3AQ45056870-31B634B8-4320-476D-9F53-4797DA580EDBQ46175985-77538951-284B-4855-83D0-3209CA738EFAQ47119162-227311D2-381D-41B6-9EC1-A7E6363A60F1Q47136729-38CEACA1-A3F2-4D64-8415-8197F6D8D099Q47156351-5ABC007C-9206-4E99-9125-8A1B1C98B805Q47214374-F116E123-2882-4802-B63C-21F709FB9D06Q47250493-B8585BCE-1D08-41ED-9430-2DD9C553AF8DQ47250841-0CA32A18-61D9-4C8E-9A7E-445C9CA4227CQ47426457-273B28CE-E7F3-4F88-A48B-F2B24EB2576BQ47825143-E7D7F9F4-44E0-4B48-8662-7A2B6F6E0A72Q47899183-E7778709-81B0-43E4-AB21-88213C1FFE4DQ47961415-B3F5F823-9D50-4DAE-8CB2-2913CE2F2789Q48001323-5AE57545-6461-457C-87A9-1B92FD745157Q48013012-7EE7D094-BB7B-4412-A626-C5AF6D326CD0Q52098047-FAB40045-5E2F-4565-8A28-3360E1ACBC6CQ52559905-0603D2F9-D70F-4AD6-9A2E-DE779215FA69Q52581734-D87AA98C-D588-4133-8D9A-0FE62563D955Q54112682-C934CA41-2F07-4768-BBF4-EB0AE68C679FQ54942435-6E78D028-B102-48C5-A82F-E3F2C355B183Q54950354-3C8096DA-319D-4E25-8C35-DE87AF36B8FDQ54962187-13C7CBCD-2125-4875-8A50-F8D10C64BD18
P2860
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferio
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dexamethasone and supportive c ...... ts from a phase 3, non-inferio
@en
Dexamethasone and supportive c ...... ts from a phase 3, non-inferio
@nl
type
label
Dexamethasone and supportive c ...... ts from a phase 3, non-inferio
@en
Dexamethasone and supportive c ...... ts from a phase 3, non-inferio
@nl
prefLabel
Dexamethasone and supportive c ...... ts from a phase 3, non-inferio
@en
Dexamethasone and supportive c ...... ts from a phase 3, non-inferio
@nl
P2093
P2860
P1433
P1476
Dexamethasone and supportive c ...... ts from a phase 3, non-inferio
@en
P2093
Barbara Moore
Benjamin Sydes
Caroline Lee
Cheryl Pugh
David Ardron
Iona Brisbane
Kathryn Waite
Mahesh K Parmar
Matthew Nankivell
Neil Bayman
P2860
P304
P356
10.1016/S0140-6736(16)30825-X
P407
P577
2016-09-02T00:00:00Z